OBJECTIVES: This study was performed to analyse the impacts of functional mitral stenosis (MS) following mitral valve (MV) repair on late cardiac function and new onset of atrial fibrillation or survival.
INTRODUCTION
Mitral valve (MV) repair is a well-established treatment method for Type II mitral regurgitation (MR) [1] . The long-term clinical outcome of this procedure and durability of MV functionality are good; however, some long-term adverse events have been reported after this procedure, such as congestive cardiac failure and thromboembolic events, which are potentially associated with functional mitral stenosis (MS) [2, 3] .
Functional MS is a well-recognized complication after restrictive MV annuloplasty for functional MR associated with dilated ischaemic/non-ischaemic cardiomyopathy [4] . We recently reported that the use of a small prosthetic ring for annuloplasty may also be associated with functional MS even after MV repair for Type II MR, although the determinants and impact of functional MS have not been clarified [5] . Additionally, Bothe et al. [6] suggested the use of a flexible partial band for annuloplasty in MV repair for Type II MR to prevent functional post-repair MS because this type of prosthesis decreases strain on the anterior mitral leaflet to maintain motion of the aortic-mitral curtain. In contrast, the use of a partial band for patients with anterior leaflet prolapse may be associated with recurrent MR, as we recently reported [7] . Moreover, other repair techniques such as resection and suturing, chordal replacement or edge-to-edge repair may be a cause of functional MS [8] [9] [10] . Furthermore, the relationship between functional MS and long-term cardiac function is not fully understood. Therefore, we reviewed an institutional series of patients undergoing MV repair for Type II MR to explore the determinants of functional MS after MV repair and the impacts of functional MS on long-term outcomes.
MATERIALS AND METHODS

Study cohort and data collection
In this observational study, we retrospectively analysed the departmental surgical database containing a consecutive series of 602 patients who underwent MV repair for Type II MR using a prosthetic ring or band in our institute from 2001 to 2017. Patients who underwent concomitant aortic valve surgery were excluded. Medical charts, operation reports and referral letters were reviewed to collect data, which were further supplemented by telephone interviews of patients under the care of distant physicians. The follow-up rate for survival was 99%, and the mean follow-up period was 5.7 ± 4.3 years. All patients gave written informed consent for surgery and the use of data for diagnostic and research purposes prior to the surgery. The institutional review board approved the study and waived the need for patient consent.
Surgical indication and procedure
Surgical indications were preoperatively determined by the heart team comprising cardiologists, cardiac surgeons and associated co-medical staff members according to established guidelines [11] . We thoroughly assessed the MV structure by preoperative transoesophageal echocardiography to determine the ring size or repair technique in all cases of Type II MR. Actually, the standard technique involved resection and suturing of the posterior leaflet and replacement of the chordae tendineae by Gore-Tex sutures; it was completed by annuloplasty using a prosthetic full ring or partial band and supplemented by cleft/indentation approximation or edge-to-edge repair when needed. The annuloplasty prosthesis size was selected according to the intertrigonal distance measured with the sizer provided and without 'downsizing'. When the intertrigonal distance was obscure, the length of the anterior leaflet was used for prosthesis size selection. The mean ring size was small (28-29 mm), and we consider that the small body size of Asian patients was the main contributor to selection of a smaller ring than in reports from Western countries. Concomitant cardiac procedures included coronary artery bypass grafting, tricuspid annuloplasty and the maze procedure. Concomitant tricuspid annuloplasty was considered in patients with mild or moderate secondary tricuspid regurgitation (TR) with a dilated annulus (> _40 mm or >21 mm/ m 2 ) and in patients with severe secondary TR undergoing leftsided valve surgery. A minimally invasive approach through a right minithoracotomy was used in 138 (22.9%) patients. Even when the mean gradient was >5.0 mmHg intraoperatively, we could allow elevation of the mean transmitral pressure gradient (MTPG) in most cases because intraoperative cardiac function is considered to be a physiologically fluctuating entity that might be subject to loading conditions, afterload and the catecholamine state.
Echocardiography and cohort grouping
All cohorts were examined by transthoracic and/or transoesophageal echocardiography preoperatively and by transthoracic echocardiography within 14 days postoperatively. Additionally, patients who made annual postoperative visits to our outpatient clinic were examined by transthoracic echocardiography. Standard data were obtained from the official echocardiographic report. The degree of functional MS on postoperative echocardiography (individually assessed by an expert engineer and expert doctor according to established guidelines [11] ) were also obtained from the official echocardiographic report. MTPG was estimated from the transmitral velocity flow curve using the modified Bernoulli equation. The TR pressure gradient (P RV-RA ) was defined as the right ventricular systolic pressure (systolic pulmonary artery pressure) minus the right atrial pressure [12] . The echocardiographic data of the patients with recurrent MR, which was defined as moderate or severe MR after the initial repair (MR of > _3 at follow-up) were not included in this study (n = 63). Recurrent MR was detected in 13 patients postoperatively and 48 patients during follow-up.
Functional MS was stratified as mild, moderate or severe (MTPG of <5.0, 5-10 or >10 mmHg, respectively) according to the guideline [11] . Patients with an MTPG of > _5 mmHg were categorized into the MS group (n = 51), and the other patients were categorized into the no-MS group (n = 551). Only 1 cohort showed severe MS; therefore, comparisons were performed between patients with mild (n = 551) and moderate or severe (n = 51) functional MS after MV repair.
Statistical analysis
Categorical data are presented as number (percentage) in Table 1 and Supplementary Material, Tables S1 and S2, and the normality distributions of continuous data were evaluated using the Shapiro-Wilk test. If the distributions were normal, the continuous data are shown as mean ± standard deviation; if not, they are shown as median and interquartile range. Data in Table  1 and Supplementary Material, Table S3 , were compared by univariable analyses using the v 2 test for categorical variables, the Mann-Whitney U-test for continuous variables with a normal distribution and the Student's t-test for continuous variables with a non-normal distribution. A logistic regression model was used to predict the risk factors for MS. Important variables were selected by a stepwise regression method from among variables with a univariable P-value of <0.2. Consequently, 4 variables (ring size, edge-to-edge repair, preoperative left atrial (LA) diameter and Grade > _3 preoperative TR) were entered into the multivariable logistic regression model to identify the independent risk factors for MS. Survival, freedom from major adverse cardiac and cerebrovascular events (MACCE) and freedom from new onset of atrial fibrillation (AF) and combined end-point curves were obtained using the Kaplan-Meier method and compared between groups using the log-rank test. Echocardiographic measures of cardiac function were analysed throughout the study period. A mixed-effects model with repeated measures was fit to evaluate the association between cardiac function and the presence of MS. The fixed effects were the patient group, time after the operation and patient group-by-time after operation interaction; the random effect was patients. All available data were used for each analysis without imputing missing data. Missing values in repeatedly measured data were handled using the direct likelihood method [13] with a mixed-effects model for repeated measures. A P-value of < _0.05 was considered statistically significant. All statistical analyses were performed using the JMP 11 statistical software package (SAS Institute, Inc., Cary, NC, USA).
RESULTS
Annuloplasty prosthesis size: single determinant of functional mitral stenosis after mitral valve repair
Patient characteristics and preoperative echocardiographic findings were not significantly different between the 2 groups ( Table 1 ). The repair techniques were not significantly different between the MS and no-MS groups. Moreover, the choice of prosthetic ring type was not significantly different between the groups (Supplementary Material, Table S1 ). The prosthetic ring size was significantly smaller in the MS group than in the no-MS group (28.0 ± 1.9 vs 28.8 ± 2.1 mm, respectively; P = 0.01). Supplementary Material, Table S2 presents more details of the surgical procedure for each prolapse lesion in both groups. For bileaflet prolapse lesions, a significantly higher rate of patients underwent edge-to-edge repair in the MS group than in the no-MS group. The statistical analysis of risk factors for MS using a multivariable logistic regression model including ring size, edge-to-edge repair, preoperative LA diameter and Grade > _3 preoperative TR showed that only ring size was an independent predictor of MS (Table 2 ). Supplementary Material, Fig. S1 shows the relationship between MTPG and ring size. A smaller ring size tended to produce a greater MTPG. Especially for small ring sizes of 26-30 mm, there were significant differences in the MPTG of 26 vs 28 mm (P = 0.004), 26 vs 30 mm (P < 0.0001) and 27 vs 30 mm (P = 0.02).
Impact of functional mitral stenosis on long-term survival or adverse events
The overall 30-day mortality rate after MV repair was 0.16%. One in-hospital death caused by postoperative low output syndrome was reported. There were 30 late deaths (4.8%) during the follow-up: 4 in the MS group and 26 in the no-MS group. Twelve deaths were cardiac related, while 16 deaths were non-cardiac related. The 5-and 10-year survival rates after MV repair were 96.6% and 91.2%, respectively, for all patients. Survival at 5 and 10 years was not significantly different between the MS and no-MS groups (log-rank P = 0.63) (Fig. 1A) . MACCE was defined as any of the following complications: all-cause death, cerebrovascular event, subsequent cardiac surgery, ischaemic heart disease and hospitalization for heart failure, but not new onset of AF. The 5-and 10-year rates of freedom from MACCE were 90.7% and 86.8% in the MS group and 85.6% and 72.4% in the no-MS group, respectively. There was no significant difference in the freedom from MACCE between the 2 groups (log-rank P = 0.35) (Fig. 1B) . No systolic anterior motion was found in any patient during follow-up.
Progressive load in the left atrium and right heart by functional mitral stenosis
The postoperative MR grade was lower than the preoperative grade in both groups. Within 14 days postoperatively, the MR grade, left ventricular end-diastolic diameter (LVEDD), left ventricular end-systolic diameter, fractional shortening and TR grade were not significantly different between the MS and no-MS groups (Supplementary Material, Table S3 ). In contrast, the LA diameter and P RV-RA were higher in the MS group than in the no-MS group. MTPG was significantly different between the 2 groups. One patient in the MS group showed a gradient of >10 mmHg. Serial echocardiography data were then assessed after MV repair with a median echocardiographic follow-up of 1.9 years and an interquartile range of echocardiographic followup of 0.5-5.7 years. A mixed-effects model with repeated measures was used to evaluate the association between cardiac function over time and patient group (MS vs no-MS group). MR severity, MTPG and LVEDD were compared between the MS and no-MS groups throughout the follow-up period (Fig. 2) . MR severity was not significantly different between the 2 groups at the beginning of the follow-up period (P = 0.17). MR severity then significantly increased over time in both groups (P = 0.028); however, the rate of progression of MR severity was not statistically different between the 2 groups ( Fig. 2A) . MTPG was significantly higher in the MS group than in the no-MS group throughout the study period (P < 0.0001). MTPG significantly increased over time in both groups (P = 0.0003); however, the rate of progression of MTPG was not significantly different between the 2 groups (P = 0.11) (Fig. 2B) . The LVEDD was not significantly different at the beginning of the follow-up period (P = 0.184). The LVEDD significantly increased over time in both groups (P = 0.0079); however, the rate of progression of LVEDD was not statistically different between the 2 groups (P = 0.35) (Fig. 2C) .
Notably, in contrast, the LA diameter was significantly greater in the MS group than in the no-MS group over time (P = 0.0015) (Fig. 2D) . The LA diameter significantly increased over time in both groups (P < 0.0001), while the rate of progression of the LA diameter was greater in the MS group (0.65 ± 0.12 mm/year) than in the no-MS group (0.33 ± 0.13 mm/year, P = 0.013). Moreover, there was no significant difference in the P RV-RA between the 2 groups at the beginning of the follow-up period, while the P RV-RA significantly increased over time in both groups (P < 0.0001). Of note, the rate of progression of P RV-RA was significantly greater in the MS group (0.72 ± 0.16 mm/year) than in the no-MS group (0.35 ± 0.17 mm/year, P = 0.03) (Fig. 2E) . Additionally, TR severity was greater in the MS group than in the no-MS group over time (P = 0.034), while TR severity significantly increased over time in both groups (P < 0.0001). Finally, the rate of progression of TR severity was significantly greater in the MS group (0.072 ± 0.014 per year) than in the no-MS group (0.034 ± 0.015 per year, P = 0.0113) (Fig. 2F) .
Association of new onset of atrial fibrillation after mitral valve repair with functional mitral stenosis
New-onset AF after MV repair was assessed throughout the study period. Fifty-one patients with chronic AF both preoperatively and postoperatively and 3 patients with a permanent pacemaker preoperatively were excluded from this analysis. During the follow-up period, new onset of AF was found in 37 (6.7%) patients [30 (5.9%) in the no-MS group and 7 (15.9%) in the MS group]. The 5-and 10-year rates of new onset of AF in the no-MS group were 3.8% and 16.9%, respectively, and those in the MS group were 21.6% and 37.5%, respectively (log-rank P = 0.003) (Fig. 3) . The cumulative incidence function from which we eliminated the competing risk of death was performed between the 2 groups (Supplementary Material, Fig. S2 ). New-onset AF in Fig. 3 and the cumulative incidence curve were similar.
DISCUSSION
In this study, 51 (8%) patients showed a > _5-mmHg pressure gradient across the MV, despite a competent MV postoperatively. An independent risk factor for a postoperative gradient of > _5 mmHg was the size of the prosthetic ring or band. Although there was no difference in survival, adverse events or left ventricular performance between the MS and no-MS groups, the LA diameter, P RV-RA and TR severity progressively worsened in the MS group compared with the no-MS group. Notably, the MS group was more likely to develop new onset of AF than the no-MS group in the long term. Functional MS after MV repair is well known in clinical practice but has not been fully studied with respect to its determinants or long-term impacts [14, 15] . Changes in transmitral flow after MV repair reportedly result in turbulence above and below the MV, leading to inflammation and pannus formation around the prosthetic ring and leaflets in association with the type and/or size of the prosthetic ring and causing progression of functional MS [16, 17] . Mesana et al. [4] reported that functional MS after MV repair was more likely to occur in patients with a small-sized, full prosthetic ring. In the present study, the size of the prosthesis was a risk factor for functional MS, which is consistent with the previous report; however, a full ring was not a risk factor in the present study. This inconsistency might be explained by the difference in prolapsing lesions between the report by Mesana et al. [4] and the present study. Mesana et al. [4] reported that all patients had posterior leaflet prolapse, whereas 18.1% of patients in our series showed an anterior lesion only. As a result, chordal replacement was more frequently performed in our series than in the study by Mesana et al. [4] . Therefore, a full ring for a posterior lesion only might be a risk factor for functional MS after MV repair, although further studies involving techniques such as stress echocardiography as reported by Mesana et al. [4] are warranted.
We previously found that a small-sized mitral annuloplasty generated an elevation of the MPTG after repair [5] . However, the current study focused on the impacts of functional MS after MV repair on long-term cardiac performance. As a result, progression of functional MS, in association with progressive LA dilatation, right heart load and, importantly, new onset of AF after MV repair, was of great interest in this study. Patients with MR are considered to develop progressive LA dilatation, pulmonary hypertension and new onset of AF, as shown in the present study. However, the grade of residual MR after repair was not significantly different between the 2 groups throughout our study period. Therefore, we consider that the impact of residual MR on the study outcome was minimal.
Although the mechanism or determinant of progression of functional MS were revealed in this study, the size and/or type of prosthesis might affect the long-term MV function and pathology. A rigid ring reportedly impairs the natural motion of the MV, distorts the anterior leaflet, reduces the orifice area and, consequently, increases the systolic anterior motion [18, 19] . Even in patients with a competent MV, turbulent blood flow around the MV (which is dependent upon the type of ring) may lead to an inflammatory reaction in the leaflet in conjunction with prosthesis material-related inflammation. This leads to restricted leaflet motion and pannus formation over time, which play major roles in the pathology of functional MS after MV repair. In the present study, despite the significant load in the right heart in the MS group, there was no significant difference in survival or MACCE between the 2 groups. Functional MS may have been progressing, not yet having reached a severity sufficient to induce a clinically significant difference. Further long-term studies are warranted.
The difference in the mean ring size between the 2 groups was statistically significant; however, it was only 1 mm, perhaps giving the impression that the difference is not clinically significant. Regardless, we consider that this small difference is important in producing clinically significant functional MS in the The 5-and 10-year rates of new onset of atrial fibrillation in patients with MS were 21.6% and 37.5%, respectively. The 5-and 10-year rates of new onset of atrial fibrillation in patients without MS were 3.8% and 16.9%, respectively. There was a significant difference between the 2 groups (log-rank P = 0.003). MS: mitral stenosis; Pts: patients. long term. When surgeons must choose between 2 ring sizes intraoperatively, our results indicate that the larger one should be chosen. A previous study showed that ring size mismatch is associated with an increased risk of recurrent MR after mitral repair for ischaemic MR [20] . However, in MV repair for Type II MV disease, the risk factors for functional MS and recurrent MR are different. In our previous study [7] , the risk factor for recurrent MR was found to be the ring type, not the ring size, indicating that a small ring does not protect against recurrent MR after MV repair for Type II dysfunction.
Limitations
This study is limited by its retrospective design. First, the surgical procedures were selected by an individual surgeon as the optimal procedure at the time. Prosthesis selection was therefore variable. However, the core procedure, such as chordal replacement or resection and suturing, was consistent with previously reported procedures, consequently eliminating bias related to the core procedure and increasing the significance of prosthesis selection. However, the repair technique, especially resection and suturing for posterior leaflet prolapse, must have influenced the leaflet motion, which can be associated with functional MS. The influence of the repair technique may need to be prospectively evaluated by 3D echocardiography. Second, assessment of cardiac function after MV repair should not be treated as a simple time-related binary event. Even if some changes in cardiac function were detected when the patients underwent echocardiographic examinations in our institution, we could not determine when those changes in cardiac function had occurred and whether they continued because cardiac function is a physiologically fluctuating entity that might be subject to loading conditions, afterload and the catecholamine state. Additionally, most of the patients were examined by institutional echocardiography several times annually and, importantly, during follow-up. Therefore, a mixed-effects model was used so that these influences were treated as simple time-dated binary events. Finally, data regarding the effective mitral orifice area or coaptation length, which we considered to be important in this study, were sometimes missing from patient reports. We considered that recalculation of the effective orifice area or coaptation length from the recorded film would substantially reduce the accuracy and objectivity. Therefore, MTPG was selected to assess functional MS after repair for Type II dysfunction.
CONCLUSION
In conclusion, annuloplasty using a small-sized ring in MV repair for Type II MR was associated with a postoperative high-pressure gradient across the MV, LA dilatation, TR and new onset of AF despite a competent MV.
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